Trial
NCT02497612
To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine and Artefenomel in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Sanofi
Collaborators
Medicines for Malaria Venture
Condition
Plasmodium Falciparum Infection
Intervention
Ferroquine SSR97193
Why stopped
All treatment arms met the futility criteria for efficacy during the pre-planned interim analysis, therefore the study was stopped.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-24